The Damon Runyon Cancer Research Foundation is inviting applications for the Damon Runyon-Rachleff Innovation Award.
The annual program is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis, or treatment of cancer. The award is specifically designed to provide funding to extraordinary early-career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances in the field.
Grants of up to $300,000 over two years will be awarded in support of novel, exceptionally creative research with the strong potential for high impact in the cancer field.
To be eligible, applicants (including non-U.S. citizens) must be conducting independent basic or translational/clinical research at a research institution in the United States. In addition, applicants must be a tenure-track assistant professor within the first four years of obtaining his/her initial assistant professor position; a clinical instructor or senior clinical fellow (in the final year of his/her sub-specialty training) holding an M.D. who is pursuing a period of independent research before taking a tenure-track faculty position; or a distinguished fellow with an exceptional record of research accomplishment identified by his/her institution to pursue an independent research program and who has dedicated laboratory space.
For complete program guidelines and application instructions, see the Damon Runyan Research Foundation's website.